ARTICLE | Emerging Company Profile
Click: personalized digital therapeutics for cognitive, neurobehavioral disorders
Click harnesses user experience data to develop apps for neurobehavioral disorders
January 3, 2020 6:39 PM UTC
Click is developing a pipeline of personalized prescription digital therapeutics that could be used alone or in combination with traditional therapeutics to treat cognitive and neurobehavioral disorders.
Launched in 2012, Click Therapeutics Inc. markets a smartphone app dubbed Clickotine to treat smoking cessation and has a pipeline of eight apps in indications “where behavioral and cognitive intervention could really move the needle on a clinically relevant primary endpoint,” said Chief Strategy Officer Austin Speier. ...